Progress in 3D Conformal Radiation Treatment of Prostate Cancer

REFERENCES

• ICRU Report No. 50. International Commission on Radia-tion Units and Measurements: prescribing, recording, and reporting photon beam therapy. Washington, DC: Interna-tional Commission on Radiation Units and Measurements, 1993.
   Google Scholar
• Nishidai T, Nagata Y, Takahashi M, et al. CT simulator: a new 3-D planning and simulating system for radiotherapy. Part 1: Description of system. Int J Radiat Oncol Biol Phys 1990; 18: 499–504.
   PubMedGoogle Scholar
• Takahashi S. Conformation radiotherapy. Acta Radiol; (Suppl 1) 1965; 142.
   Google Scholar
• Umegaki Y. Dose distribution in the moving field radiother-apy. Nippon Acta Radiol 1960; 20: 2191–209.
   Google Scholar
• Sandler HM. 3-D conformal radiotherapy for prostate cancer: the University of Michigan experience. Basel: S. Karger 1996: 238–43.
   Google Scholar
• Lichter AS. Three-dimensional conformal radiation therapy: a testable hypothesis. Int J Radiat Oncol Biol Phys 1991; 21: 853–5.
   Google Scholar
• McShan DL, Fraass BA, Lichter AS. Full integration of the beams eye view concept in computerized treatment planning. Int J Radiat Oncol Biol Phys 1990; 18: 1489–94.
   Google Scholar
• Sandler HM, Perez-Tamayo C, Ten Haken RK, Lichter AS. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992; 23: 53–4.
   PubMed Web of Science ®Google Scholar
• Ten Haken RK, Perez-Tamayo C, Tesser RJ, McShan DL, Fraass BA, Lichter AS. Boost treatment of the prostate using shaped, fixed fields. Int .1- Radiat Oncol Biol Phys 1989; 16: 193–200.
   PubMedGoogle Scholar
• Leibel SA, Heimann R, Kutcher GJ, et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a Phase I dose-escalation study. Int .1- Radiat Oncol Biol Phys 1993; 28: 55–65.
   Web of Science ®Google Scholar
• Leibel SA, Ling CC, Kutcher GJ, Mohan R, Cordon-Cordo C, Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int .1- Radiat Oncol Biol Phys 1991; 21: 805–11.
   PubMed Web of Science ®Google Scholar
• Ling C, Burman C, Chui CS, et al. Perspectives of multidimen-sional conformal radiation treatment. Radiother Oncol 1993; 29: 129–39.
   PubMedGoogle Scholar
• Ling CC, Burman C, Chui C, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int .1- Radiat Oncol Biol Phys 1996; 35: 721–30.
   PubMedGoogle Scholar
• LoSasso T, Chui C, Kutcher G, Leibel S, Fuks Z, Ling C. The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int .1- Radiat Oncol Biol Phys 1993; 25: 161–70.
   PubMed Web of Science ®Google Scholar
• Mohan R, Mageras G, Baldwin B, et al. Clinically relevant optimization of 3D conformal treatments. Med Phys 1992; 19: 933–44.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Leibel SA, Kutcher GJ, Kelson S, Ling C, Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am 1995; 1: 142–50.
   Google Scholar
• Bonin S, Hanlon A, Lee W, Movsas B, Al-Saleem T, Hanks G. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer 1997; 79: 75–80.
   Google Scholar
• Hanks GE, Hanlon AL, Schultheiss TE, et al. Conformal external beam treatment of prostate cancer. Urol 1997; 50: 87–92.
   PubMed Web of Science ®Google Scholar
• Hanks GE, Lee WR, Hanlon AL, et al. Conformal technique dose escalation for prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/ml. Int .1- Radiat Oncol Biol Phys 1996; 35: 861–8.
   PubMed Web of Science ®Google Scholar
• Lee WR, Hanks GE, Hanlon A, Schultheiss TE, Hunt MA. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int .1- Radiat Oncol Biol Phys 1996; 35: 251–7.
   Google Scholar
• Nicolaou N, Watkins-Bruner D, Hanks GE, Hanlon A. Preser-vation of sexual function in young prostate cancer patients after radiation therapy: a positive factor in choice of a treatment modality. Int .1- Radiat Oncol Biol Phys 1996; 36: 270.
   Google Scholar
• Pinover WH, Hanlon AL, Hanks GE. The correlation of PSA nadir and biochemical freedom from cancer after external bBeam radiation therapy. Cancer. (Submitted 1997.)
   Google Scholar
• Schultheiss TE, Hanks GE, Hunt MA, Lee WR. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995; 32: 643–50.
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int .1- Radiat Oncol Biol Phys 1997; 37: 3–12.
   PubMed Web of Science ®Google Scholar
• Soffen EM, Hanks GE, Hwang CC, Chu JCH. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int .1- Radiat Oncol Biol Phys 1991; 20: 141–6.
   PubMed Web of Science ®Google Scholar
• Hanks GE. Strategies for improving the outcome of patients with poor prognosis prostate cancer. Acta Oncol 1998; 37: 5–10.
   PubMed Web of Science ®Google Scholar
• Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization and future directions. Int .1- Radiat Oncol Biol Phys 1998; 41: 501–10.
   PubMed Web of Science ®Google Scholar
• Rajapakshe R, Shalev S. Noise analysis in real-time portal imaging. I. Quantization noise. Med Phys 1994; 21: 1263–8.
   Google Scholar
• Stafford PM, Martin EE, Chu JCH, Davidson BA, Hanks GE. Digital imaging in the radiation oncology environment: a personal computer local area network solution. J Digit Imaging 1991; 4: 177–84.
   Google Scholar
• Corn BW, Hanks GE, Schultheiss TE, Hunt MA, Lee WR, Coia LR. Conformal treatment of prostate cancer with im-proved targeting: superior prostate-specific antigen response compared to standard treatment. Int .1- Radiat Oncol Biol Phys 1995; 32: 325–30.
   PubMedGoogle Scholar
• Hanks GE, Schultheiss TE, Hunt MA, Epstein B. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int .1-Radiat Oncol Biol Phys 1995; 31: 25–29.
   PubMed Web of Science ®Google Scholar
• Hanks GE. External beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. NCI Monographs 1988; 7: 75–84.
   Google Scholar
• Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocar-cinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int .1- Radiat Oncol Biol Phys 1991; 21: 935–9.
   PubMed Web of Science ®Google Scholar
• Zelefsky M, Leibel S, Gaudin P, et al. Dose escalation with three-dimensional conformal radiation therapy affects the out-come in prostate cancer. Int .1- Radiat Oncol Biol Phys 1998; 41: 491–500.
   PubMed Web of Science ®Google Scholar
• Pollack A, Zagars G. External beam radiotherapy dose re-sponse of prostate cancer. Int .1- Radiat Oncol Biol Phys 1997; 39: 1011–8.
   PubMed Web of Science ®Google Scholar
• Hanks G, Hanlon A, Pinover W, Horwitz E, Schultheiss T. Survival advantage for prostate cancer patients treated with high dose 3D conformal radiation. Cancer J Sci Am. (Submit-ted 1998.)
   Google Scholar
• Lattanzi J, McNeely S, Barnes S, Das I, Schultheiss TE, Hanks GE. Initial results of using daily CT localization to correct portal error in prostate cancer. Int .1- Radiat Oncol Biol Phys 1997; 39: 193.
   Google Scholar
• Movsas B, Chapman J, Horwitz E, et al. Hypoxic regions exist in human prostate carcinoma. Urol 1998.
   Google Scholar